Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

VTVT — vTv Therapeutics Inc. SEC Filings | FilingIndex

VTVTNasdaq

vTv Therapeutics Inc.

Pharmaceutical Preparations · DE · CIK 1641489

Developing orally administered therapies for metabolic and inflammatory diseases, primarily cadisegliatin for type 1 diabetes

+ Watch View on EDGAR ↗

$129M

Market cap

$37.65

Last close

+3.8%

1D

+6.6%

5D

93K

Volume

Price · last 40 sessions+15.8%

May 4L $30.44 · H $38.43Jun 30

259

Total filings

Jun 29, 2026

Last filing

12/31

Fiscal year end

All 8-K · 171 10-Q · 33 10-K · 11 DEF 14A · 11 DEFA14A · 8 424B5 · 6 S-1/A · 6 SC 13D · 4

DEFA14ADEFA14AJun 10, 2026 DEFA14ADEFA14AMar 18, 2021 DEFA14ADEFA14AMay 22, 2020 DEFA14ADEFA14AApr 30, 2020 DEFA14ADEFA14AMar 15, 2019 DEFA14A

Similar companies

Comparable business profile · signals at a glance

GPCRStructure Therapeutics Inc.$3.1B+3.8%CTNMContineum Therapeutics, Inc.$444.2M+9.3%CRNXCrinetics Pharmaceuticals, Inc.$3.6B+1.3%MDGLMADRIGAL PHARMACEUTICALS, INC.$11.1B+1.8%SIONSionna Therapeutics, Inc.

DEFA14A

Mar 16, 2018

DEFA14ADEFA14AMar 20, 2017

DEFA14ADEFA14AMar 24, 2016

$1.6B

+2.4%

LXRXLEXICON PHARMACEUTICALS, INC.$852.9M-9.1%